Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

US Patent 10781215 · Granted Sep 22, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted N(-methyl-D3)pyridazine-3-carboxamide or M-(methyl-D3)-nicotinamide 2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2025
Pharmaceutical compositions comprising WRN helicase inhibitors2025
Triazolopyridinyl compounds as kinase inhibitors2024
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2023
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2023
Sulfone pyridine alkyl amide-substituted heteroaryl compounds2023
Triazolopyridinyl compounds as kinase inhibitors2023
Substituted bicyclic compounds2023
Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 2023